SCHEMBL5987487

SCHEMBL5987487

[CH2]CC#CCC(C)CCCCCCCCC[CH2]

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5986803 1.00 LMNA (0.31) LMNA
SCHEMBL5985935 0.91
SCHEMBL5986300 0.89 LMNA (0.32) LMNA
SCHEMBL5986513 0.86 RAB9A (0.31) LMNA
SCHEMBL5986018 0.86 LMNA (0.30) LMNA
SCHEMBL5985168 0.86 RAB9A (0.31) LMNA
SCHEMBL5986902 0.86 RAB9A (0.31) LMNA
SCHEMBL5984512 0.86 LMNA (0.30) LMNA
SCHEMBL5986433 0.86 RAB9A (0.31) LMNA
SCHEMBL5985219 0.86 RAB9A (0.31) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060124444-A1 Method and device for deodorization and purification of exhaust gas or flue gas NAKAMURA SHINICHI 2006-06-15 US disclosed
US-7018993-B2 Antiandrogenic agent CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-03-28 US disclosed
US-20030164309-A1 Method and device for deodorization and purification of exhaust gas or flue gas OMEGA CO., LTD. 2003-09-04 US disclosed
US-20030158164-A1 Novel antiandrogenic agent CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-21 US disclosed
EP-1304334-A1 NOVEL ANTIANDROGENIC AGENT CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-04-23 EP disclosed
EP-1219631-A1 ANTIANDROGEN AGENTS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-07-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158164-A1 Novel antiandrogenic agent NR5A1, CYP19A1, HSD17B11 LMNA 2182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.